Advertisement

FDA / Research

BerGenBio shares soar on COVID-19 drug trial news

By Terje Solsvik and Gwladys Fouche OSLO (Reuters) – Shares of Norway’s BerGenBio more than doubled on Wednesday after a cancer drug it is developing was selected for a British trial of potential COVID-19 treatments,...

Read More

For latest news and updates
Email-id is invalid